Long-molecule scars of backup DNA repair in BRCA1-and BRCA2-deficient cancers

被引:9
|
作者
Setton, Jeremy [1 ]
Hadi, Kevin [2 ,3 ,4 ]
Choo, Zi-Ning [2 ,3 ,4 ]
Kuchin, Katherine S. [2 ,3 ,5 ]
Tian, Huasong [2 ,3 ]
Da Cruz Paula, Arnaud [6 ]
Rosiene, Joel [2 ,3 ]
Selenica, Pier [6 ]
Behr, Julie [2 ,3 ,5 ]
Yao, Xiaotong [2 ,3 ,5 ]
Deshpande, Aditya [2 ,3 ,5 ]
Sigouros, Michael [7 ]
Manohar, Jyothi [7 ]
Nauseef, Jones T. [3 ,7 ,8 ,9 ]
Mosquera, Juan-Miguel [2 ,7 ,9 ]
Elemento, Olivier [7 ,9 ,10 ]
Weigelt, Britta [6 ]
Riaz, Nadeem [1 ]
Reis-Filho, Jorge S. [6 ]
Powell, Simon N. [1 ]
Imielinski, Marcin [2 ,3 ,7 ,9 ,11 ,12 ]
机构
[1] Mem Sloan Kettering Canc Ctr, Dept Radiat Oncol, New York, NY 10065 USA
[2] Weill Cornell Med, Dept Pathol & Lab Med, New York, NY 10065 USA
[3] New York Genome Ctr, New York, NY 10013 USA
[4] Weill Cornell Med, Physiol & Biophys PhD program, New York, NY USA
[5] Weill Cornell Med, Triinst PhD Program Computat Biol & Med, New York, NY USA
[6] Mem Sloan Kettering Canc Ctr, Dept Pathol, New York, NY USA
[7] Englander Inst Precis Med, Weill Cornell Med, New York, NY 10065 USA
[8] Weill Cornell Med, Dept Med, Div Hematol & Med Oncol, New York, NY USA
[9] Weill Cornell Med, Meyer Canc Ctr, New York, NY 10065 USA
[10] Weill Cornell Med, Dept Physiol & Biophys, New York, NY USA
[11] Weill Cornell Med, Inst Computat Biomed, New York, NY 10065 USA
[12] NYU, Perlmutter Canc Ctr, Dept Pathol, Grossman Sch Med, New York, NY 10012 USA
关键词
BREAST-CANCER; BRCA2; INSTABILITY; RECOMBINATION; SIGNATURES; MUTATIONS; CELLS; DEFICIENCY;
D O I
10.1038/s41586-023-06461-2
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Homologous recombination (HR) deficiency is associated with DNA rearrangements and cytogenetic aberrations(1). Paradoxically, the types of DNA rearrangements that are specifically associated with HR-deficient cancers only minimally affect chromosomal structure(2). Here, to address this apparent contradiction, we combined genome-graph analysis of short-read whole-genome sequencing (WGS) profiles across thousands of tumours with deep linked-read WGS of 46 BRCA1- or BRCA2-mutant breast cancers. These data revealed a distinct class of HR-deficiency-enriched rearrangements called reciprocal pairs. Linked-read WGS showed that reciprocal pairs with identical rearrangement orientations gave rise to one of two distinct chromosomal outcomes, distinguishable only with long-molecule data. Whereas one (cis) outcome corresponded to the copying and pasting of a small segment to a distant site, a second (trans) outcome was a quasi-balanced translocation or multi-megabase inversion with substantial (10 kb) duplications at each junction. We propose an HR-independent replication-restart repair mechanism to explain the full spectrum of reciprocal pair outcomes. Linked-read WGS also identified single-strand annealing as a repair pathway that is specific to BRCA2 deficiency in human cancers. Integrating these features in a classifier improved discrimination between BRCA1- and BRCA2-deficient genomes. In conclusion, our data reveal classes of rearrangements that are specific to BRCA1 or BRCA2 deficiency as a source of cytogenetic aberrations in HR-deficient cells.
引用
收藏
页码:129 / +
页数:28
相关论文
共 50 条
  • [31] Phase II study of talazoparib in advanced cancers with BRCA1/2, DNA repair, and PTEN alterations
    Piha-Paul, Sarina A.
    Tseng, Chieh
    Leung, Cheuk Hong
    Yuan, Ying
    Karp, Daniel D.
    Subbiah, Vivek
    Hong, David
    Fu, Siqing
    Naing, Aung
    Rodon, Jordi
    Javle, Milind
    Ajani, Jaffer A.
    Raghav, Kanwal P.
    Somaiah, Neeta
    Mills, Gordon B.
    Tsimberidou, Apostolia M.
    Zheng, Xiaofeng
    Chen, Ken
    Meric-Bernstam, Funda
    NPJ PRECISION ONCOLOGY, 2024, 8 (01)
  • [32] BRCA1 and BRCA2 heterozygosity and repair of X-ray-induced DNA damage
    Nieuwenhuis, B
    Van Assen-Bolt, AJ
    Van Waarde-Verhagen, MAWH
    Sijmonds, RH
    Van der Hout, AH
    Bauch, T
    Streffer, C
    Kampinga, HH
    INTERNATIONAL JOURNAL OF RADIATION BIOLOGY, 2002, 78 (04) : 285 - 295
  • [33] We of BRCA1 and BRCA2 as regulators of DNA repair, transcription, and cell cycle in response to DNA damage
    Yoshida, K
    Miki, Y
    CANCER SCIENCE, 2004, 95 (11): : 866 - 871
  • [34] Defining a BRCA1/BRCA2 dependent pathway of DNA repair in human breast cancer
    Powell, S. N.
    Luo, C. M.
    Willers, H.
    Kachnic, L. A.
    Taghian, A. G.
    RADIOTHERAPY AND ONCOLOGY, 2006, 78 : S12 - S12
  • [35] DNA repair gene SNPs as modifiers of BRCA1 and BRCA2 phenotypic expression.
    Chenevix-Trench, G
    Spurdle, A
    Chen, X
    Hopper, J
    Apicella, C
    Newman, B
    Cook, M
    Peock, S
    Easton, D
    AMERICAN JOURNAL OF HUMAN GENETICS, 2002, 71 (04) : 252 - 252
  • [36] Therapeutic Targeting of BRCA1-Mutated Breast Cancers with Agents That Activate DNA Repair
    Alli, Elizabeth
    Solow-Cordero, David
    Casey, Stephanie C.
    Ford, James M.
    CANCER RESEARCH, 2014, 74 (21) : 6205 - 6215
  • [37] The DNA strand breaking nucleoside analogue sapacitabine sensitizes Brca2-deficient ovarian cancer cells and synergizes with PARP inhibitors
    Liu, Xiaojun
    Jiang, Yingjun
    Nowak, Billie
    Qiang, Bethany
    Cheng, Nancy
    Plunkett, William
    CANCER RESEARCH, 2016, 76
  • [38] A Rare Cell-penetrating Anti-DNA Antibody Inhibits DNA Repair, Sensitizes Tumors To DNA-damaging Therapy, and is Synthetically Lethal to BRCA2-deficient Cancer Cells
    Hansen, J. E.
    Chan, G.
    Liu, Y.
    Gera, J.
    Sweasy, J. B.
    Sung, P.
    Rockwell, S.
    Nishimura, R. N.
    Weisbart, R. H.
    Glazer, P. M.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2012, 84 (03): : S163 - S163
  • [39] BRCA1 alterations with additional DNA damage repair gene defects may confer chemoresistance to BRCA-like breast cancers
    Kaneko, Yasuhiko
    Takada, Mamoru
    Nagai, Shigenori
    Haruta, Masayuki
    Sugino, Ryuichi
    Tozuka, Katsunori
    Takei, Hiroyuki
    Inoue, Kenichi
    Kurosumi, Masafumi
    Miyazaki, Masaru
    Sato, Yusuke
    Ogawa, Seishi
    CANCER SCIENCE, 2018, 109 : 435 - 435
  • [40] Multi-omics analysis reveals distinct non-reversion mechanisms of PARPi resistance in BRCA1-versus BRCA2-deficient mammary tumors
    Bhin, Jinhyuk
    Dias, Mariana Paes
    Gogola, Ewa
    Rolfs, Frank
    Piersma, Sander R.
    de Bruijn, Roebi
    de Ruiter, Julian R.
    van den Broek, Bram
    Duarte, Alexandra A.
    Sol, Wendy
    van der Heijden, Ingrid
    Andronikou, Christina
    Kaiponen, Taina S.
    Bakker, Lara
    Lieftink, Cor
    Morris, Ben
    Beijersbergen, Roderick L.
    van de Ven, Marieke
    Jimenez, Connie R.
    Wessels, Lodewyk F. A.
    Rottenberg, Sven
    Jonkers, Jos
    CELL REPORTS, 2023, 42 (05):